Cardiovascular diseases remain the leading cause of global mortality and disability. Corsera Health is transforming the future of human health by enabling earlier prediction of atherosclerotic cardiovascular disease (ASCVD) and developing a once-annual RNAi medicine to prevent cumulative cardiovascular damage. Powered by Nobel Prize-winning science, AI technology, efficient manufacturing, a disruptive business model, and a proven team of industry leaders, we are redefining cardiovascular wellness and empowering people to live longer, healthier lives.

By combining decades of RNAi innovation with world-leading expertise in cardiovascular disease prediction, manufacturing, evidence generation, and commercialization, Corsera Health is poised to change the trajectory of cardiovascular disease—enhancing healthspan, reducing healthcare costs, and boosting human productivity.